Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Smartphone-based distress screening, information provision, and psychotherapy for reducing psychological distress among AYA cancer survivors: protocol for a fully decentralized multicenter randomized controlled clinical trial.
Akechi T, Furukawa TA, Hashimoto H, Harada Y, Ito Y, Furukawa Y, Kitano A, Maeda N, Kojima Y, Tada Y, Watanabe A, Kurata A, Matsubara T, Sakurai N, Uchitomi Y, Okamura M, Fujimori M. Akechi T, et al. Among authors: kojima y. Jpn J Clin Oncol. 2024 Aug 28:hyae111. doi: 10.1093/jjco/hyae111. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39193645
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
Aiba H, Kojima Y, Shimoi T, Sudo K, Yazaki S, Imai T, Yoshida A, Iwata S, Kobayashi E, Kawai A, Arakawa A, Ogawa C, Kimura H, Yonemori K. Aiba H, et al. Among authors: kojima y. Jpn J Clin Oncol. 2023 Jun 29;53(7):604-610. doi: 10.1093/jjco/hyad031. Jpn J Clin Oncol. 2023. PMID: 37093679 Review.
Feasibility of an Electronic Patient-Reported Outcome Tool for Screening Distress and Supportive Care Needs of Adolescents and Young Adults with Cancer.
Hirayama T, Ishiki H, Yanai Y, Horiguchi S, Sugisawa A, Sato J, Kojima R, Sato K, Mizuta T, Kojima R, Udagawa R, Kojima Y, Satomi E. Hirayama T, et al. Among authors: kojima r, kojima y. J Adolesc Young Adult Oncol. 2024 Feb;13(1):138-146. doi: 10.1089/jayao.2023.0014. Epub 2023 May 26. J Adolesc Young Adult Oncol. 2024. PMID: 37252764 Free PMC article.
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.
Mizuno T, Kojima Y, Yonemori K, Yoshida H, Sugiura Y, Ohtake Y, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Shimomura A, Noguchi E, Kato T, Shimoi T, Uno M, Ishikawa M, Fujiwara Y, Ohe Y, Tamura K. Mizuno T, et al. Among authors: kojima y. Oncol Lett. 2020 Oct;20(4):38. doi: 10.3892/ol.2020.11899. Epub 2020 Jul 23. Oncol Lett. 2020. PMID: 32802162 Free PMC article.
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
Mizuno T, Kojima Y, Yonemori K, Yoshida H, Sugiura Y, Ohtake Y, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Shimomura A, Noguchi E, Kato T, Shimoi T, Uno M, Ishikawa M, Fujiwara Y, Ohe Y, Tamura K. Mizuno T, et al. Among authors: kojima y. Oncol Lett. 2020 Dec;20(6):336. doi: 10.3892/ol.2020.12200. Epub 2020 Oct 7. Oncol Lett. 2020. PMID: 33123247 Free PMC article.
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.
Sanomachi T, Okuma HS, Kitadai R, Kawachi A, Yazaki S, Tokura M, Arakaki M, Saito A, Kita S, Yamamoto K, Maejima A, Kojima Y, Nishikawa T, Sudo K, Shimoi T, Noguchi E, Fujiwara Y, Sugino H, Shiino S, Suto A, Yoshida M, Yonemori K. Sanomachi T, et al. Among authors: kojima y. Front Oncol. 2023 Mar 27;13:1157789. doi: 10.3389/fonc.2023.1157789. eCollection 2023. Front Oncol. 2023. PMID: 37051545 Free PMC article.
2,252 results